NovoCure NVCR
NASDAQ NVCR
$15.92 -0.03 (-0.19%)
At close: Oct 1, 2026 · 4:00 PM EDT

NovoCure (NVCR) Gross Profit (2014 - 2026)

Updated

NovoCure's Gross Profit was $142.48 million in Q2 2026, up 21.4% from $117.33 million a year earlier and up 5.4% from the prior quarter.

Analysis

NovoCure (NVCR) Gross Profit (2014 - 2026) Analysis & Trends

On a trailing twelve-month basis, NovoCure's Gross Profit was $532.27 million through Jun 30, 2026, up 10.6% year-over-year; for FY2025, it came in at $488.47 million, up 4.4% from FY2024.

  • Gross Profit shows a five-year compound annual growth rate of 4.7% (FY2020 to FY2025).
  • In earlier years, Gross Profit was $468.04 million in FY2024 (+22.8%), $381.06 million in FY2023 (-9.9%), $422.97 million in FY2022 (+0.7%) and $420.15 million in FY2021 (+8.3%).
  • The Q2 2026 figure marks the highest quarterly Gross Profit in data going back to Q3 2014.
  • Compared with a year earlier, Gross Profit has increased for 11 straight quarters, with growth averaging 13.5% over the last eight quarters.
  • The best year-over-year quarter for Gross Profit over five years was Q4 2024 (growth of 26.2%); the worst was Q2 2023 (a decline of 18.1%).
  • Per Business Quant data, NVCR's Gross Profit in the three quarters before Q2 2026 was $135.13 million (Q1 2026), $132.19 million (Q4 2025) and $122.48 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
API Access

NovoCure Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=NVCR&period=max&api_key=YOUR_API_KEY